论文部分内容阅读
最近的一项研究表明,由Ｃｕｒｉｓ生物制药公司研制开发的“刺猬蛋白”(ＳｏｎｉｃＨｅｄｇｅｈｏｇｐｒｏｔｅｉｎ)在动物试验中成功地使存在糖尿病性神经病变的神经系统恢复了功能。在该项由英国Ｍａｎｃｈｅｓｔｅｒ大学的ＤａｖｉｄＴｏｍｌｉｎｓｏｎ教授负责的研究中,患
A recent study showed that “SonicHedgehog protein” developed by Curis Biopharmaceuticals succeeded in restoring the function of the nervous system in the presence of diabetic neuropathy in animal experiments. In the study led by Professor David Tomlinson from Manchester University, England